Effects of 22-oxa-calcitriol on podocyte injury in adriamycin-induced nephrosis

Aida Lydia1, Katsuhiko Asanuma, Kanae Nonaka

  • 1Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.

Abstract

Insights

22-oxa-calcitriol (OCT), a vitamin D analog, reduced proteinuria and protected podocytes in adriamycin (ADR)-induced nephrosis mice. This study highlights OCT's potential therapeutic benefit for kidney disease.

Area of Science:

  • Nephrology
  • Endocrinology
  • Pharmacology

Background:

  • Vitamin D analogs show promise in reducing proteinuria and kidney disease progression in animal models.
  • The renoprotective effects of vitamin D in adriamycin (ADR)-induced nephrosis mice remain largely unexplored.
  • This study investigates the therapeutic potential of 22-oxa-calcitriol (OCT) in ADR-induced nephrosis.

Purpose of the Study:

  • To evaluate the renoprotective effects of OCT in ADR-induced nephrosis mice.
  • To determine OCT's ability to prevent podocyte injury and reduce proteinuria.

Main Methods:

  • Adriamycin (ADR) induced nephrosis in mice, with treatment groups receiving either ADR alone or ADR plus OCT.
  • Podocyte injury was assessed using TUNEL assay for apoptosis, cell counting, immunofluorescence, Western blot for protein expression, and electron microscopy for foot process effacement.
  • Control groups included mice treated with OCT only.

Main Results:

  • OCT treatment significantly reduced proteinuria and improved glomerulosclerosis and interstitial fibrosis.
  • Restoration of nephrin, CD2AP, and podocin expression was observed, while dendrin expression remained unchanged.
  • OCT partially prevented foot process effacement and mitigated podocyte loss in ADR-treated mice.

Conclusions:

  • 22-oxa-calcitriol (OCT) demonstrates significant renoprotective effects in ADR-induced nephrosis mice.
  • OCT reduces podocyte injury, proteinuria, and renal fibrosis, suggesting therapeutic potential for kidney disease.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...